Abstract
Purpose
In the 6-hydroxydopamine (6-OHDA) rat model of Parkinson's disease (PD), it is important to determine lesion severity. This evaluation can be performed in vivo, through evaluation of dopamine (DA)-dependent motor function or with small animal positron emission tomography (microPET), or at postmortem, by examining markers for DA neurons.
Procedures
Rats were given mild or severe unilateral 6-OHDA lesions, scanned with the tracer [11C](±)dihydrotetrabenazine ([11C]DTBZ), and tested on a tapered/ledged beam-walking task. At postmortem, autoradiography was performed with [11C]DTBZ.
Results
Autoradiography was significantly correlated with microPET and behavioral scores, whereas the microPET and behavioral data were not significantly correlated.
Conclusions
This study shows that behavioral analysis, microPET, and autoradiography are all good tools for measuring the integrity of the DA system, and demonstrates the utility of the tapered/ledged beam-walking test to screen for lesion severity, as well as the importance of including postmortem analysis after in vivo imaging studies.
Similar content being viewed by others
References
Ungerstedt U (1968) 6-Hydroxy-dopamine induced degeneration of central monoamine neurons. Eur J Pharmacol 5:107–110
Costall B, Naylor RJ, Pycock C (1976) Non-specific supersensitivity of striatal dopamine receptors after 6-hydroxydopamine lesion of the nigrostriatal pathway. Eur J Pharmacol 35:276–283
Morelli M, Fenu S, Garau L, Di Chiara G (1989) Time and dose dependence of the ‘priming’ of the expression of dopamine receptor supersensitivity. Eur J Pharmacol 162:329–335
Klug JM, Norman AB (1993) Long-term sensitization of apomorphine-induced rotation behavior in rats with dopamine deafferentation or excitotoxin lesions of the striatum. Pharmacol Biochem Behav 46:397–403
Tai YC, Ruangma A, Rowland D, et al. (2005) Performance evaluation of the microPET focus: A third-generation microPET scanner dedicated to animal imaging. J Nucl Med 46:455–463
Yang Y, Tai YC, Siegel S, et al. (2004) Optimization and performance evaluation of the microPET II scanner for in vivo small-animal imaging. Phys Med Biol 49:2527–2545
Knoess C, Siegel S, Smith A, et al. (2003) Performance evaluation of the microPET R4 PET scanner for rodents. Eur J Nucl Med Mol Imaging 30:737–747
Tai C, Chatziioannou A, Siegel S, et al. (2001) Performance evaluation of the microPET P4: A PET system dedicated to animal imaging. Phys Med Biol 46:1845–1862
Tai YC, Chatziioannou AF, Yang Y, et al. (2003) MicroPET II: design, development and initial performance of an improved microPET scanner for small-animal imaging. Phys Med Biol 48:1519–1537
Huang N, Ase AR, Hebert C, van Gelder NM, Reader TA (1997) Effects of chronic neuroleptic treatments on dopamine D1 and D2 receptors: Homogenate binding and autoradiographic studies. Neurochem Int 30:277–290
Rinne JO, Laihinen A, Ruottinen H, et al. (1995) Increased density of dopamine D2 receptors in the putamen, but not in the caudate nucleus in early Parkinson's disease: A PET study with [11C]raclopride. J Neurol Sci 132:156–161
Narang N, Wamsley JK (1995) Time dependent changes in DA uptake sites, D1 and D2 receptor binding and mRNA after 6-OHDA lesions of the medial forebrain bundle in the rat brain. J Chem Neuroanat 9:41–53
Nikolaus S, Larisch R, Beu M, Vosberg H, Muller-Gartner HW (2001) Imaging of striatal dopamine D2 receptors with a PET system for small laboratory animals in comparison with storage phosphor autoradiography: A validation study with 18F-(N-Methyl)Benperidol. J Nucl Med 42:1691–1696
Doudet DJ, Jivan S, Ruth TJ, Holden JE (2002) Density and affinity of the dopamine D2 receptors in aged symptomatic and asymptomatic MPTP-treated monkeys: PET studies with [11C]raclopride. Synapse 44:198–202
Wilson JM, Nobrega JN, Carroll ME, et al. (1994) Heterogeneous subregional binding patterns of 3H-WIN 35,428 and 3H-GBR 12,935 are differentially regulated by chronic cocaine self-administration. J Neurosci 14:2966–2979
Kilbourn MR, Sherman PS, Pisani T (1992) Repeated reserpine administration reduces in vivo [18F]GBR 13119 binding to the dopamine uptake site. Eur J Pharmacol 216:109–112
Doudet DJ (2001) PET studies in the MPTP model of Parkinson's disease. Adv Neurol 86:187–195
Lee CS, Samii A, Sossi V, et al. (2000) In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease. Ann Neurol 47:493–503
Wilson JM, Kish SJ (1996) The vesicular monoamine transporter, in contrast to the dopamine transporter, is not altered by chronic cocaine self-administration in the rat. J Neurosci 16:3507–3510
Vander Borght T, Kilbourn M, Desmond T, Kuhl D, Frey K (1995) The vesicular monoamine transporter is not regulated by dopaminergic treatments. Eur J Pharmacol 294:577–583
Frey KA, Wieland DM, Kilbourn MR (1998) Imaging of monoaminergic and cholinergic vesicular transporters in the brain. Adv Pharmacol 42:269–272
Paxinos G, Watson C (1997) The rat brain in stereotaxic coordinates. San Diego: Academic Press
Schallert T, Woodlee MT (2005) Orienting and Placing. In: Whishaw IQ, Kolb B (eds) The Behavior of the Laboratory Rat: A Handbook with Tests. New York: Oxford University Press, pp 129–140
Zhao CS, Puurunen K, Schallert T, Sivenius J, Jolkkonen J (2005) Behavioral and histological effects of chronic antipsychotic and antidepressant drug treatment in aged rats with focal ischemic brain injury. Behav Brain Res 158:211–220
Feeney DM, Gonzalez A, Law WA (1982) Amphetamine, haloperidol, and experience interact to affect rate of recovery after motor cortex injury. Science 217:855–857
Walsh SL, Wagner GC (1992) Motor impairments after methamphetamine-induced neurotoxicity in the rat. J Pharmacol Exp Ther 263:617–626
Bowenkamp KE, Ujhelyi L, Cline EJ, Bickford PC (2000) Effects of intra-striatal GDNF on motor coordination and striatal electrophysiology in aged F344 rats. Neurobiol Aging 21:117–124
Zar JH (1999) Biostatistical Analysis. Upper Saddle River: Prentice-Hall
Rubins DJ, Meadors AK, Yee S, Melega WP, Cherry SR (2001) Evaluation of a stereotactic frame for repositioning of the rat brain in serial positron emission tomography imaging studies. J Neurosci Methods 107:63–70
Jewett DM, Kilbourn MR, Lee LC (1997) A simple synthesis of [11C]dihydrotetrabenazine (DTBZ). Nucl Med Biol 24:197–199
Alexoff D, Vaska P, Marsteller D, et al. (2003) Reproducibility of 11C-raclopride binding in the rat brain measured with microPET R4: effects of scatter correction and tracer specific activity. J Nucl Med 44:815–822
Strome EM, Jivan S, Doudet DJ (2005) Quantitative in vitro phosphor imaging using [3H] and [18F] radioligands: The effects of chronic desipramine treatment on serotonin 5-HT2 receptors. J Neurosci Methods 141:143–154
Darchen F, Masuo Y, Vial M, Rostene W, Scherman D (1989) Quantitative autoradiography of the rat brain vesicular monoamine transporter using the binding of [3H]dihydrotetrabenazine and 7-amino-8-[125I]iodoketanserin. Neuroscience 33:341–349
Masuo Y, Pelaprat D, Scherman D, Rostene W (1990) [3H]Dihydrotetrabenazine, a new marker for the visualization of dopaminergic denervation in the rat striatum. Neurosci Lett 114:45–50
Nikolaus S, Larisch R, Beu M, et al. (2003) In vivo measurement of D2 receptor density and affinity for 18F-(3-N-methyl) benperidol in the rat striatum with a PET system for small laboratory animals. J Nucl Med 44:618–624
Matsumura A, Mizokawa S, Tanaka M, et al. (2003) Assessment of microPET performance in analyzing the rat brain under different types of anesthesia: Comparison between quantitative data obtained with microPET and ex vivo autoradiography. Neuroimage 20:2040–2050
Moore AH, Osteen CL, Chatziioannou A, Hovda DA, Cherry SR (2000) Quantitative assessment of longitudinal metabolic changes in vivo after traumatic brain injury in the adult rat using FDG-microPET. J Cereb Blood Flow Metab 20:1492–1501
Momosaki S, Hatano K, Kawasumi Y, et al. (2004) Rat-PET study without anesthesia: Anesthetics modify the dopamine D1 receptor binding in rat brain. Synapse 54:207–213
Vollenweider FX, Vontobel P, Oye I, Hell D, Leenders KL (2000) Effects of (S)-ketamine on striatal dopamine: A [11C]raclopride PET study of a model psychosis in humans. J Psychiatr Res 34:35–43
Kobayashi K, Inoue O, Watanabe Y, Onoe H, Langstrom B (1995) Difference in response of D2 receptor binding between 11C-N-methylspiperone and 11C-raclopride against anesthetics in rhesus monkey brain. J Neural Transm Gen Sect 100:147–151
Mazziotta JC, Phelps ME, Plummer D, Kuhl DE (1981) Quantitation in positron emission computed tomography: 5. Physical–anatomical effects. J Comput Assist Tomogr 5:734–743
Schallert T, Fleming SM, Leasure JL, Tillerson JL, Bland ST (2000) CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury. Neuropharmacology 39:777–787
Acknowledgments
We are grateful for technical assistance from Siobhan McCormick (microPET technician), Rick Kornelsen, and Jessica Grant (animal technicians), and to the staff at the UBC Animal Resource Unit. The authors would also like to acknowledge the staff of the UBC/TRIUMF PET group, and in particular Dr. Tom Ruth (Head), for their support of these studies. This work was supported by The Canadian Foundation for Innovation, The Canadian Institutes of Health Research, and the Michael Smith Foundation for Health Research. A version of this work was presented at the Academy of Molecular Imaging 2005 Annual Meeting, Orlando, FL.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Strome, E.M., Cepeda, I.L., Sossi, V. et al. Evaluation of the Integrity of the Dopamine System in a Rodent Model of Parkinson’s Disease: Small Animal Positron Emission Tomography Compared to Behavioral Assessment and Autoradiography. Mol Imaging Biol 8, 292–299 (2006). https://doi.org/10.1007/s11307-006-0051-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11307-006-0051-6